Background: CHI3L1 (YKL-40) is up-regulated in a variety of inflammatory conditions and cancers. We have previously reported elevated CHI3L1 concentration in the cerebrospinal fluid (CSF) of human and non-human primates with lentiviral encephalitis and using immunohistochemistry showed that CHI3L1 was associated with astrocytes.

Methods: In the current study CHI3L1 transcription and expression were evaluated in a variety of acute and chronic human neurological diseases.

Results: ELISA revealed significant elevation of CHI3L1 in the CSF of multiple sclerosis (MS) patients as well as mild elevation with aging. In situ hybridization (ISH) showed CHI3L1 transcription mostly associated with reactive astrocytes, that was more pronounced in inflammatory conditions like lentiviral encephalitis and MS. Comparison of CHI3L1 expression in different stages of brain infarction showed that YKL40 was abundantly expressed in astrocytes during acute phases and diminished to low levels in chronic infarcts.

Conclusions: Taken together, these findings demonstrate that CHI3L1 is induced in astrocytes in a variety of neurological diseases but that it is most abundantly associated with astrocytes in regions of inflammatory cells.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2892443PMC
http://dx.doi.org/10.1186/1742-2094-7-34DOI Listing

Publication Analysis

Top Keywords

chi3l1 ykl-40
8
astrocytes acute
8
acute chronic
8
neurological diseases
8
chi3l1
8
inflammatory conditions
8
lentiviral encephalitis
8
chi3l1 transcription
8
astrocytes
5
vivo chi3l1
4

Similar Publications

Biomarkers.

Alzheimers Dement

December 2024

INSERM UMR-S1144, Paris, France.

Background: Increasing evidence supports the use of plasma biomarkers of amyloid, tau, neurodegeneration and neuroinflammation for diagnosis of dementia. However, their performance for positive and differential diagnosis of dementia with Lewy bodies (DLB) in clinical settings is still uncertain.

Method: We conducted a retrospective biomarker study in two tertiary memory centers, Paris Lariboisière and CM2RR Strasbourg, France, enrolling patients with DLB (n=104), Alzheimer's disease (AD, n=76) and neurological controls (NC, n=27).

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Mölndal, Gothenburg, Sweden.

Background: Emerging evidence underscores the importance of neuroinflammation in the progression of Alzheimer's disease (AD) pathophysiology. Recent studies indicate the involvement of the inflammatory mechanisms both in amyloid- β (Aβ) and tau deposition in the brain. Nevertheless, due to the complexity of the immune responses and the intricate interplay between the peripheral and the central nervous systems, identifying biomarkers that reflect the brain´s inflammatory state in AD has been a challenge.

View Article and Find Full Text PDF

Background: Vascular Contributions to Cognitive Impairment and Dementia (VCID) is the second most common cause of dementia. Cerebral amyloid angiopathy (CAA), as one of the vascular pathologies underlying VCID, often coexists with Alzheimer's disease (AD). The New World non-human primate species, squirrel monkey (SQM), is a preclinical model of AD pathology that naturally develops extensive age-associated CAA, and therefore holds immense translational value to study biomarkers and novel therapeutic approaches for AD and CAA.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Stanford University, Stanford, CA, USA.

Background: Astrocytes that become reactive in response to damage (e.g., due to typical brain aging or Alzheimer's Disease/AD pathologies) can have both adaptive (e.

View Article and Find Full Text PDF

Background: Obstructive sleep apnea (OSA) is associated with hypoxia-induced neuronal impairment and dysfunction-key risk factors for the pathogeneses of age-related neurodegenerative diseases such as Alzheimer's disease (AD). This study examined longitudinal associations between OSA severity and CSF biomarkers associated with AD, synaptic dysfunction, and neuroinflammation in a sample of late-middle-aged adults with increased risk for AD.

Method: N=25 cognitively unimpaired adults (64% female, mean age 65.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!